Allosteric equilibria of thrombin and its precursors
凝血酶及其前体的变构平衡
基本信息
- 批准号:9789457
- 负责人:
- 金额:$ 37.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAddressAreaAutolysisBasic ScienceBindingBiologyBlood Coagulation FactorBlood coagulationCatalysisClinical TreatmentComplementCore ProteinDepositionDevelopmentEngineeringEnzyme PrecursorsEnzymesEquilibriumFamilyFibrinolysisGoalsHydrogen BondingImmune responseInflammationInvestigationKineticsKnowledgeLigand BindingLinkMeasurementMeasuresMolecular ConformationPeptide HydrolasesProcessPropertyProtein CProteinsRegulationResearch Project GrantsRoentgen RaysRoleSideStructureTestingThrombinTimeTrypsinWorkbasebiophysical techniquescatalystdata warehousemembermutantphase I trialprethrombinssynergism
项目摘要
The proposed research project focuses a recently uncovered, paradigm-shifting structure-function link relevant
to the entire family of trypsin-like enzymes to which thrombin belongs. A pre-existing, allosteric equilibrium
between ensembles of closed (E*) and open (E) conformations of the active site influences the level of activity
and mechanism of binding in the protease. The equilibrium also exists in the zymogen and explains the
spontaneous autoactivation observed with several proteins involved in blood coagulation, immune response,
fibrinolysis and development. Observational evidence of the E*-E equilibrium comes from a large body of
structures currently deposited in the Protein Data Bank. Additional independent evidence comes from rapid
kinetics measurements of ligand binding to the active site of protease and zymogen that support conformational
selection as a general mechanism of recognition in the trypsin fold. Studies under specific aim 1 will test the
hypothesis that protease and zymogen undergo the E*-E equilibrium in solution and that the relative distribution
of E* and E influences activity in the protease and the mechanism of activation in the zymogen. A significant
component of these studies will involve pioneering NMR (2D and 19F) measurements of thrombin and
prethrombin-2 with the goal of elucidating, for the first time, the structure and dynamics of their free
conformation(s) in solution. We will focus on the likely structural determinants of the E*-E equilibrium and critical
residues that decorate the entrance to the active site region in the 215-217 segment (W215, G216, E217), the
60-loop (W60d), the autolysis loop (W148) and the 190-193 corridor (E192). The functional role of these residues
will be tested by rapid kinetics measurements of ligand binding to the active site of wild-type and mutants of
thrombin and its direct zymogen precursor prethrombin-2. These studies will advance our understanding of a
basic structure-function link of the trypsin fold and will provide background for studies to be carried out under
specific aim 2. Members of the trypsin family of proteases, to which thrombin belongs, are expressed as inactive
zymogens and irreversibly converted to the mature protease by proteolytic cleavage at R15 in the activation
domain. The cleavage generates a new N-terminus that inserts into the protein core and H-bonds to the side
chain of residue D194. Elucidating how the Huber-Bode mechanism of zymogen activation described above is
linked to the allosteric E*-E equilibrium will be center stage in our investigation. We will perturb the critical I16-
D194 H-bond with several substitutions that weaken or abolish the interaction. Each mutant will be studied by
rapid kinetics to directly measure the E*-E distribution in solution. Additionally, key mutants such as D914A will
be characterized structurally for the first time by X-ray and NMR to complement studies of prethrombin-2 and
thrombin under specific aim 1. Developments from this specific aim will elucidate the linkage between two critical
features of the trypsin fold, i.e., the allosteric E*-E equilibrium and the Huber-Bode mechanism, in ways that will
advance our basic knowledge of one the largest families of proteases.
提出的研究项目侧重于最近发现的,范式转换的结构-功能联系相关
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Enrico Di Cera其他文献
Enrico Di Cera的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Enrico Di Cera', 18)}}的其他基金
Allosteric equilibria of thrombin and its precursors
凝血酶及其前体的变构平衡
- 批准号:
10429976 - 财政年份:2019
- 资助金额:
$ 37.88万 - 项目类别:
PROTEASE SPECIFICITY AND REGULATION PROTEIN ENGINEERING
蛋白酶特异性和调控蛋白质工程
- 批准号:
8168792 - 财政年份:2010
- 资助金额:
$ 37.88万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Research Grant